Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm®
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

NEW ON THE MARKET
Me too: rifamycin (RELAFALK) against traveller's diarrhea
LARYNGOMEDIN OCTENIDIN ANTISEPT against sore throat

THERAPY FROM A CRITICAL VIEWPOINT
Stress ulcer prophylaxis with proton pump inhibitors: what's new?

a-t READER'S QUESTIONS AND COMMENTS
QT prolongation: is escitalopram better than citalopram?

BEWARE MISINFORMATION
Dasatinib (e.g. SPRYCEL): for chronic myelogenous leukaemia only the original preparation?

IN BRIEF
Rivaroxaban as antithrombotic therapy after transcatheter aortic-valve replacement (TAVI): more harm than benefit
Sunscreen: benefit documented, risks of absorbed UV filters remains unclear

CURRENT ADR NETWORK REPORT
Severe allergic reaction with flurbiprofen lozenges (e.g. DOBENDAN DIREKT)

SIDE EFFECTS
Xylometazoline nasal drops – risk of incorrect dosing in infants
Impulse control disorders with selective serotonin reuptake inhibitors (SSRIs)  free article 
Panic attacks with levonorgestrel-releasing intrauterine devices (e.g. MIRENA)

e a-t ON THE INTERNET
Larotrectinib (VITRAKVI) for solid tumours
© 2024 arznei-telegramm